ARLINGTON, Va. — Face-to-face medication therapy management services can improve health outcomes for patients with diabetes, according to a new study.
The 224-patient study, conducted by researchers at the University of Minnesota and healthcare institutions in the area and published in the journal Population Health Management, found that diabetes patients experienced better outcomes when pharmacist-provided MTM was part of their overall disease therapy. While patients receiving MTM services showed improvement, those who discontinued soon returned to measurement levels similar to the ones they had before they started.
"This study really showcases the positive impact of pharmacist-provided MTM services for patients suffering from chronic diseases," National Association of Chain Drug Stores president and CEO Steven Anderson said. "The face-to-face medical intervention by a pharmacist is irreplaceable and — as evidenced in this study — an important component of chronic disease patient management."